164 related articles for article (PubMed ID: 23295287)
1. Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation.
DellaManna T; Silva MR; Chacra AR; Kunii IS; Rolim AL; Furuzawa G; Maciel RM; Reis AF
Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):490-5. PubMed ID: 23295287
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutations in the glucokinase gene in people clinically characterized as MODY2 without a family history of diabetes.
Lopez AP; de Dios A; Chiesa I; Perez MS; Frechtel GD
Diabetes Res Clin Pract; 2016 Aug; 118():38-43. PubMed ID: 27289208
[TBL] [Abstract][Full Text] [Related]
3. Functional Characterization of a Novel Heterozygous Mutation in the Glucokinase Gene That Causes MODY2 in Chinese Pedigrees.
Jiang F; Yan J; Zhang R; Ma X; Bao Y; Gu Y; Hu C
Front Endocrinol (Lausanne); 2021; 12():803992. PubMed ID: 34956103
[TBL] [Abstract][Full Text] [Related]
4. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
[TBL] [Abstract][Full Text] [Related]
6. Characterization of glucokinase polymorphisms associated with maturity-onset diabetes of the young (MODY2) in Jordanian population.
Al-Sheyab F; Khamaiseh E; Halaweh MA; Khaul RW
Tsitol Genet; 2009; 43(5):58-63. PubMed ID: 20458967
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the GCK gene in 79 MODY type 2 patients: A multicenter Turkish study, mutation profile and description of twenty novel mutations.
Aykut A; Karaca E; Onay H; Gökşen D; Çetinkalp Ş; Eren E; Ersoy B; Çakır EP; Büyükinan M; Kara C; Anık A; Kırel B; Özen S; Atik T; Darcan Ş; Özkınay F
Gene; 2018 Jan; 641():186-189. PubMed ID: 29056535
[TBL] [Abstract][Full Text] [Related]
8. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
[TBL] [Abstract][Full Text] [Related]
9. A novel glucokinase deletion (p.Lys32del) and five previously described mutations co-segregate with the phenotype of mild familial hyperglycaemia (MODY2) in Brazilian families.
Giuffrida FM; Calliari LE; Manna TD; Ferreira JG; Saddi-Rosa P; Kunii IS; Furuzawa GK; Dias-da-Silva MR; Reis AF
Diabetes Res Clin Pract; 2013 May; 100(2):e42-5. PubMed ID: 23433541
[TBL] [Abstract][Full Text] [Related]
10. Glucokinase mutations in pediatric patients with impaired fasting glucose.
Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
[TBL] [Abstract][Full Text] [Related]
11. Glucokinase gene mutations (MODY 2) in Asian Indians.
Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
[TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
13. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of the glucokinase impaired function - GCK MODY today.
Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
[TBL] [Abstract][Full Text] [Related]
15. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young.
Mantovani V; Salardi S; Cerreta V; Bastia D; Cenci M; Ragni L; Zucchini S; Parente R; Cicognani A
Hum Mutat; 2003 Oct; 22(4):338. PubMed ID: 12955723
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
[TBL] [Abstract][Full Text] [Related]
17. MODY 2: mutation identification and molecular ancestry in a Brazilian family.
Mota AJ; Brüggemann S; Costa FF
Gene; 2013 Jan; 512(2):486-91. PubMed ID: 23085272
[TBL] [Abstract][Full Text] [Related]
18. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
Spégel P; Ekholm E; Tuomi T; Groop L; Mulder H; Filipsson K
Diabetes; 2013 Feb; 62(2):653-61. PubMed ID: 23139355
[TBL] [Abstract][Full Text] [Related]
19. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
20. HNF1alpha mutations are present in half of clinically defined MODY patients in South-Brazilian individuals.
Maraschin Jde F; Kannengiesser C; Murussi N; Campagnolo N; Canani LH; Gross JL; Velho G; Grandchamp B; Silveiro SP
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1326-31. PubMed ID: 19169489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
